Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02097030 · ClinicalTrials.gov registry record · NA
Clinical Evaluation of Daily Disposable Contact Lenses
A NA study, sponsored by CooperVision.
- Completed
- Registry status
- NA
- Development phase
- 35
- Enrollment target
NCT02097030 is a NA study that has completed, run by CooperVision. The registered enrollment target is 35 participants.
The verdict
NCT02097030, a NA study, has completed, sponsored by CooperVision.
- COMPLETED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
Study Summary
The objective of the study is to compare the overall subjective preference of filcon II 3 daily disposable silicone hyrogel contact lenses compared to etafilcon A and nelfilcon A daily disposable conventional hydrogel contact lenses.
Interventions
- DEVICE etafilcon A
- DEVICE filcon II 3
- DEVICE nelfilcon A
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2014-03 |
| Est. Completion | 2014-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02097030
The ClinicalTrials.gov registry entry for NCT02097030 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CooperVision, which has 64 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which etafilcon A is the first listed.
NCT02097030 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02097030 about?
NCT02097030 is a clinical study titled "Clinical Evaluation of Daily Disposable Contact Lenses". The objective of the study is to compare the overall subjective preference of filcon II 3 daily disposable silicone hyrogel contact lenses compared to etafilcon A and nelfilcon A daily disposable conventional hydrogel contact lenses.
What is the current status of trial NCT02097030?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2014-03. Estimated completion is 2014-04.
What interventions are being tested in trial NCT02097030?
The interventions under investigation include: etafilcon A (DEVICE), filcon II 3 (DEVICE), nelfilcon A (DEVICE).
Who is sponsoring clinical trial NCT02097030?
This trial is sponsored by CooperVision, which has 64 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.